Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel vs Vinorelbine in Neoadjuvant CRT for Esophageal Squamous Cell Carcinoma
NCT02465736Phase 3Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2015
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sun Yat-sen University. Started Jul 2015; status: active, not recruiting.
02
Drugs
docetaxel
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02465736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465736.